Cancer & Metabolism

Papers
(The H4-Index of Cancer & Metabolism is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-04-01 to 2026-04-01.)
ArticleCitations
The classification of obesity based on metabolic status redefines the readmission of non-Hodgkin’s lymphoma—an observational study107
FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma71
A role of arginase-1-expressing myeloid cells in cachexia48
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition42
GCN2-SLC7A11 axis coordinates autophagy, cell cycle and apoptosis and regulates cell growth in retinoblastoma upon arginine deprivation35
Ketomimetic nutrients remodel the glycocalyx and trigger a metabolic defense in breast cancer cells32
Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response30
ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma28
Lactate dehydrogenase A-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival27
Autofluorescence imaging of endogenous metabolic cofactors in response to cytokine stimulation of classically activated macrophages26
Glycemic status, insulin resistance, and mortality from lung cancer among individuals with and without diabetes26
Magnetospirillum magneticum triggers apoptotic pathways in human breast cancer cells25
Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer25
Circulating metabolome landscape in Lynch syndrome24
Steatohepatitis-induced vascular niche alterations promote melanoma metastasis22
Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress22
Correction: Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells22
Transcriptome-driven constraint-based modelling reveals metabolic targets for ovarian cancer22
CYP19A1 regulates chemoresistance in colorectal cancer through modulation of estrogen biosynthesis and mitochondrial function22
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors20
0.67062497138977